TickerFactsScreenerDevelopers

Aprea Therapeutics, Inc. (APRE) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2018: $65.68M2019: $130.09M2020: $89.02M2021: $53.08M2022: $28.79M2023: $21.61M2024: $22.85M2025: $14.60M$14.60M
2018Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$14.60M-36.1%
2024$22.85M+5.8%
2023$21.61M-24.9%
2022$28.79M-45.8%
2021$53.08M-40.4%
2020$89.02M-31.6%
2019$130.09M+98.1%
2018$65.68M—